According to a study published in the journal BMJ Open, solo artists are at an increased risk to die in comparison to artists performing in groups.
A group of researchers from the UK has said they have based their study on the assessment of 1,400 European and North American artists, who used to perform between 1956 and 2006.
After assessing them, the study researchers reached at a conclusion that chances of early death among solo artists were more than those who performed in groups. Some of the solo artists, who have died prematurely, are Michael Jackson, Whitney Houston, Jimi Hendrix and Amy Winehouse.
In order to derive complete knowledge of the artists, study researchers gathered information of their personal lives and childhood from different websites. To know their professional success, international polls were evaluated.
Honey Langcaster-James, a psychologist, who specializes in the celebrity behavior, said, "Even for the general population, psychology research has found that people with support have increased lifespan - and those in a band may benefit even more from this".
The researchers concluded by saying that the premature death risk was two times more among solo singers in comparison to group singers.
According to software giant Microsoft, the company’s Edge browser -- the default browser included in the Windows 10 OS -- consumes less battery as compared to any of the other browsers.
Touting the power-saving capabilities of its Edge...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has officially acknowledged the widely-known fact that Android's update system...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a Monday announcement, Chinese device maker Huawei...
According to software giant Microsoft, the company’s...
According to software giant Microsoft, the company’s...
According to a deal announced by Microsoft, the company’...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).